Techno Trends
Worldwide advancements and breakthroughs in pharmaceutical products and technology are thoroughly covered by Techno Trends. You may stay up to date with all the most recent pharmaceutical developments (product news and technological trends) taking place throughout the world.
Novel ZetaMet™ Technology Discovered for Metastatic Bone Cancers
Zetagen Therapeutics, discovered novel ZetaMet™ technology for the treatment of metastatic bone cancers. This technology is the first to suspend cancer inhibit pain, and regenerate bone. ZetaMet™ technology was earlier known as ZetaFuse. It is a synthetic, small-molecule, inductive biologic technology introduced to target and resolve metastatic...
Breakthrough Biology-Guided Radiotherapy* (BgRT) Discovered for the Treatment of Lung Tumors
RefleXion Medical, Inc discovered breakthrough biology-guided radiotherapy* (BgRT)for the treatment of lung cancer. Biology-guided radiotherapy(BgRT), the first and only technology has the ability to detect and treat the circulating tumours producing active emissions from each tumour....
Pear Therapeutics Developed reSET-A™ PDT Product Candidate for Alcohol Use Disorder (AUD)
Pear therapeutics developed new reSET-A™ PDT product candidate for the treatment of alcohol use disorder (AUD) PDTsare new therapeutic class designed with software to directly treat disease. Similar to traditional medicines, PDT’s are developed and tested...
Susvimo™, Breakthrough Therapy Discovered for Wet Age-Related Macular Degeneration (nAMD)
Roche discovered breakthrough therapy Susvimo™ (ranibizumab injection) for the treatment of people with neovascular or ‘wet’ age-related macular degeneration (nAMD). Susvimoearlier known as port delivery system with ranibizumab is the first and only alternative treatment in 15 years which provides standard-of-care...
Novel NonInvasive Sonic Beam Device Developed for Non-Invasive Liver Treatment
HistoSonics developed novel sonic beam therapy for the destruction of targeted liver tissue. The new targeted liver therapy helps in providing timely access to non-invasive liver treatment and destructs targeted liver tissue. This is the first automated external beam therapy which makes use of acoustic energy...
New Exo-PDAC Assay Discovered for Early Detection of Pancreatic Ductal Adenocarcinoma (PDAC)
Biological Dynamics, Inc discovered new Exo-PDAC, liquid biopsy assay for the early detection of pancreatic ductal adenocarcinoma (PDAC) in high-risk adults. Globally, pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive and lethal forms of cancer....
Novel Repotrectinib Therapeutic Option Discovered for Advanced Solid Tumors
Turning Point Therapeutics, Inc discovered novel repotrectinib, a leading drug candidate for the treatment of patients with advanced solid tumors having an NTRK gene fusion. Repotrectinib is a therapeutic option for patients who have shown progress with 1 or 2 prior TRK TKIs after treatment, with or without prior chemotherapy...
SKYTROFA® (Lonapegsomatropin-tcgd), The First Therapy Discovered for Pediatric Growth Hormone Deficiency
Acendis Pharma has made a significant discovery in the form of SKYTROFA (lonapegsomatropin-tcgd), a groundbreaking treatment for pediatric growth hormone deficiency....
New Simoa® phospho-Tau 181 (pTau-181) Blood Test Discovered for Alzheimer’s Disease
Quanterix Corporation discovers new Blood-Based pTau-181 Assay for Alzheimer’s Disease. The Simoa® phospho-Tau 181 (pTau-181) blood test will be used for diagnostic evaluation of Alzheimer’s Disease (AD). With the use of HD-X immunoassay system, the pTau-181 concentration in human serum...
Genentech Developed Breakthrough Therapy Gantenerumab for Alzheimer’s Disease
Genentech has developed a groundbreaking therapy for the treatment of early Alzheimer's disease (AD). This therapy, called Gantenerumab, is the first medicine designed to be administered at home for the treatment of Alzheimer's disease....
